-3.jpg)
History
History
Professor Michel Boiron founded ESH in 1985 at the famous “Institut Universitaire d’Hématologie (IUH)” which he directed at that time, following in the steps of Professor Jean Bernard and Professor Jean Dausset who founded the Institute in 1958. The IUH is located on the grounds of the historic university teaching hospital “Hôpital Saint Louis”, in Paris. At the time it was founded, ESH was the only institution of its kind in the world. It remains the only insitution for continuing education with a specific focus on Haematology.
The goal of the School has always been to promote communication among scientists at the pan-European level, to catalyze the creation of new trans-European basic and clinical research networks, and to contribute to the education and integration of younger scientists in the active European scientific community. The School aims to contribute to the international reputation of European science and medicine and to help to improve the quality of healthcare for patients with blood disorders.
Many haematological disorders have strong socio-economic impact for the European Union; ESH is a resource for healthcare policy decision makers to wish to address current health issues and anticapte those that are forthcoming.
The European Commission has supported ESH since 1993 through Marie Curie Actions, the EACEA’s Life-Long Learning Programme, and DG Sanco.
ESH works in partnership with many other prestigious scientific organizations and institutions. These include the European Group for Blood and Marrow Transplantation (EBMT), the European Hematology Association (EHA), the International CML Foundation (iCMLf), the International Society of Thrombosis and Haemostasis (ISTH), the American Association for Cancer Research (AACR), Eurocord, Netcord, the UT MD Anderson Cancer Center, and the Brazilian School of Haematology.
One example of a partnership that contributed to design the European Health Space for haematologists, was the development a pan-European system for the accreditation and quality control of CME live events. This system was created through a partnership between EHA and ESH, and with the EBMT and the national societies of haematology in Europe. It was funded by the European Commission.
ESH develops all its scientific projects and programmes independently. The support the School received from the pharmaceutical and biotechnology sectors in the form of educational grants dooes not impede on this independency while helping to defray the costs of conference organization and the development of distance training tools.
ESH has worked for 30 years to improve and harmonize the quality of education in haematology throughout Europe with the active implication of the world’s most prominent haematologists and haematology organisations and with the support of the European Commission and corporate partners.
In 2025, ESH Celebrated 40 Years!
40 years of leading-edge scientific, translational research and clinically oriented meetings in which outstanding international faculty actively informed, mentored, and interacted face to face with practicing biologists and clinicians from around the world, enriched by freely accessible training tools available through the ESH eLearning Centre.
In the videos below, Professor Hervé Dombret (ESH President), Professor Michael Hallek (Chairman of the Scientific Committee) and Professor Bob Löwenberg (Past-Chairman of the Scientific Committee) share reflections on the history of ESH, marking 40 years of impactful activities.
In the words of…
Participants:
“Great conferences with excellent quality and speakers, like always. They help us a lot to improve our knowledge and skills. Many congratulations for you and your team for the great organization of the ESH congresses and your professionalism. I am thanking you in advance for your help as always and for many years.”
“As PhD student it was a very enriching experience, full of opportunities to meet experts in the field and to talk with them.”
“This was one of the best conferences I have ever attended. The presentations were of exceptionally high quality, with a rigorous scientific approach and insightful discussions. The overall standard was outstanding, and the content was highly relevant and impactful. I truly appreciate the effort put into organizing such a top-tier event.”
Brief Oral Communication and Poster Presenters:
“It has been a fantastic experience to share our work in such an exceptional and inspiring scientific environment! Looking forward to the next edition!”
“I feel honoured to have been part of this ESH Conference. My deepest gratitude goes to the scientific committee for selecting my PhD work for a brief oral presentation. Taking part in such a high level Scientific Conference on research and clinical studies was truly inspiring. “
Faculty members:
“…..It’s moments like these that reaffirm my passion for advancing knowledge in the field of cancer research. It was truly a pleasure meeting fellow experts in the field and exchanging ideas. Looking forward to future collaborations!”
“An outstanding event with high-level sessions, insightful discussions, and an impressive audience. It is always inspiring to connect with colleagues from around the world, exchange knowledge, and stay up to date with the latest advancements in the field. Congratulations to the organizers for such a successful and enriching meeting! Looking forward to future opportunities to collaborate and learn together.”
Thank you to the 82 798 participants who have joined us over the years!